Explore more publications!

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on April 9, 2026

Announcing the American Board of Quality Assurance and Utilization Review Physicians (ABQAURP) 49th Annual Conference
As GLP-1 Momentum Surges, Jay Campbell Unveils Metabolic Awakening with GLP-1 Peptides to Redefine the Conversation
Dr. Ann Monis Named Honoree for South Florida Business & Wealth Prestigious Women Awards 2026
McKnight’s covers peer-reviewed Pyure study showing 48% fewer respiratory infections in long-term care
MPLT Healthcare Recognized as a 2026 SIA Best Staffing Firm to Work For
Medicare Covers PureWick®, Yet Access Challenges Persist for Patients
Massive Bio Publishes Prospective Study on AI-Driven Clinical Trial Matching in 3,804 Cancer Patients
ReviveHealth Expands Weight Health Program with Additional Care Pathways to Support Long-Term Health Outcomes
Glial Solutions Launches Nervous System-Informed Consulting for High-Pressure Workplaces
Award-Winning Documentary on Addiction Now Free to Watch on YouTube
Vita Smart Cup Massager Claims Evaluated: 2026 Report on Suction Therapy, Red Light Technology, and What Consumers Should Know Before Buying
FDA Accepts NDA for TLX101-Px (Pixclara®)
Extendicare Announces $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes
Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference
Dental Care of Stamford Challenges the Myths Holding Stamford Residents Back from the Smile They Want
Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program
eHealth Exchange Demonstrates Real-World Patient Access Capability, Advancing CMS-Aligned Network Goals
Sobi Receives Health Canada Approval for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
Sobi reçoit l’autorisation par Santé Canada pour EMPAVELIMD (pegcétacoplan) dans le traitement de la GC3 et de la GNMP-CI primitive.
Certara to Report First Quarter 2026 Financial Results on May 11th, 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions